Results 91 to 100 of about 198,739 (181)
Modelling the impact of school reopening and contact tracing strategies on Covid-19 dynamics in different epidemiologic settings in Brazil. [PDF]
Glob Epidemiol, 2022 Borges ME, Ferreira LS, Poloni S, Bagattini AM, Franco C, da Rosa MQM, Simon LM, Camey SA, Kuchenbecker RS, Prado PI, Diniz-Filho JAF, Kraenkel RA, Coutinho RM, Toscano CM. +13 moreeuropepmc +1 more sourceRegional sepsis care in Catalonia: comparative insights from a secondary analysis of the European Sepsis Care Survey. [PDF]
Crit CareCeccato A, Scheer CS, Ferrer R, Martinez ML, Cisteró B, Yébenes JC, Trenado J, Lorencio C, Linder A, Filipescu D, Idelevich EA, Giamarellos-Bourboulis EJ, Artigas A, European Sepsis Care Study Group. +13 moreeuropepmc +1 more sourceBCG vaccination to reduce the impact of COVID-19 in healthcare workers: Protocol for a randomised controlled trial (BRACE trial). [PDF]
BMJ Open, 2021 Pittet LF, Messina NL, Gardiner K, Orsini F, Abruzzo V, Bannister S, Bonten M, Campbell JL, Croda J, Dalcolmo M, Elia S, Germano S, Goodall C, Gwee A, Jamieson T, Jardim B, Kollmann TR, Guimarães Lacerda MV, Lee KJ, Legge D, Lucas M, Lynn DJ, Lynn DJ, McDonald E, Manning L, Munns CF, Perrett KP, Prat Aymerich C, Richmond P, Shann F, Sudbury E, Villanueva P, Wood NJ, Lieschke K, Subbarao K, Davidson A, Curtis N, BRACE trial Consortium Group. +37 moreeuropepmc +1 more sourceLongitudinal study on SARS-CoV-2 antibody responses in companion animals, Chile. [PDF]
Vet QAgüero B, Tischler ND, Alegria R, Cárdenas-Cáceres S, Berríos F, Espinoza P, Muena NA, Galarce N, Ramírez G, Retamal P, Neira V. +10 moreeuropepmc +1 more sourcePriporočila za obravnavo bolnic z rakom materničnega telesa
Onkologija, 2018 Barbara Šegedin, Sebastjan Merlo, Špela Smrkolj, Sonja Bebar, Ana Blatnik, Olga Cerar, Branko Cvjetičanin, Barbara Gazić, Andreja Gornjec, Borut Kobal, Mateja Krajc, Ksenija Strojnik, Manja Šešek, Erik Škof, Iztok Takač, Aleš Vakselj, Vesna Zadnik, Helena Barbara Zobec Logar +17 moredoaj Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trial. [PDF]
iScienceLuedtke A, Fong Y, van der Laan L, Heng F, Huang Y, Lu Y, Yu C, Carpp LN, Roels S, Le Gars M, Van Roey GA, Stieh DJ, Van Dromme I, Kenny A, Carone M, Hyrien O, Ayala V, Jayashankar L, Castellino F, Amoa-Awua O, Basappa M, Flach B, Lin BC, Moore C, Naisan M, Naqvi M, Narpala S, O'Connell S, Mueller A, Serebryannyy L, Castro M, Wang J, Dziubla G, Randhawa AK, Andrasik MP, Hendriks J, Truyers C, Struyf F, Schuitemaker H, Douoguih M, Kublin JG, Corey L, Neuzil KM, Bekker LG, Garrett N, Cardoso SW, DelaFontaine P, Magaret CA, Vingerhoets J, Casapia M, Losso MH, Little SJ, Gaur A, Swann E, Petropoulos CJ, McDermott AB, Sadoff J, Gray GE, Grinsztejn B, Goepfert PA, Follmann D, Roychoudhury P, Greninger AL, Koup RA, Donis RO, Gilbert PB, Immune Assays Team, Coronavirus Vaccine Prevention Network (CoVPN)/ENSEMBLE Team, United States Government (USG)/CoVPN Biostatistics Team. +68 moreeuropepmc +1 more source